Scheduled Maintenance: On-Line Store

Validating Whole Slide Imaging for Diagnostic Purposes in Pathology

Evidence-based guideline for confirming the accuracy/concordance of WSI systems for diagnostic work while ensuring proper use of the digital tool for its intended clinical applications.

Background

The US Food and Drug Administration has approved select digital whole slide imaging (WSI) systems for primary diagnoses in surgical pathology, ushering in new applications for digital pathology. The “Validating Whole Slide Imaging for Diagnostic Purposes in Pathology: Guideline Update” helps pathologists and laboratories confirm diagnostic accuracy and equivalence with light microscopy of WSI systems before they are actually used for diagnostic purposes.

We convened an expert panel of pathologists, histotechnologists, and a methodologist to develop the 2021 guideline update. The update was created using our rigorous and transparent development principles; it offers three strong recommendations and nine good practice statements, which largely reaffirm the original guideline recommendations.

Validation of WSI is crucial to ensure the quality and consistency of diagnostic performance based on digitized slides. For patients, this could mean receiving their pathologic diagnosis more quickly with the same quality test results and thereby possibly receiving treatment sooner. The guideline update is published in the Archives of Pathology & Laboratory Medicine.

Guideline Information

  • Guideline Status: Active
  • Originally published: December 2013
  • Update published: April 2022
  • Update published online ahead of print: May 18, 2021
  • Collaborators: American Society for Clinical Pathology and Association for Pathology Informatics

Guideline Tools and Resources

Frequently Asked Questions

Have a Question or Comment?

Email the Center at center@cap.org.

Learn More

Review additional CAP evidence-based guidelines by the Center